Spinal Stenosis Market Projected to Gain Significant Value through 2032Posted by Ganesh Shinde on March 20th, 2023 During the forecast period, the spinal stenosis market is expected to grow at a CAGR of 4%. The market is expected to be worth US$ 9.42 billion in 2022 and US$ 13.94 billion by 2032. Spinal stenosis is a narrowing of the spinal column caused primarily by ageing and degenerative changes in the spine. This puts pressure on the spinal cord and spinal nerve roots, which can result in leg discomfort, numbness, or weakness. Spinal stenosis primarily affects adults over the age of 60, although it can also afflict younger people who are born with an irregular spinal canal. The three main kinds of spinal stenosis are lumbar spinal stenosis, cervical spinal stenosis, and thoracic spinal stenosis. The lower lumbar area accounts for approximately 75% of all occurrences of spinal stenosis. Radiculopathy and myelopathy are the major signs of spinal stenosis. Myelopathy is more concerning because strain on the spinal cord might result in irreversible spinal cord injury. The diagnosis of spinal stenosis requires a thorough examination of the spine. MRI scans and X-rays are the most commonly used diagnostic tests for spinal stenosis. Spinal Stenosis Market: Key Players Key companies operational in global spinal stenosis market are Medtronic Inc., DePuy Synthes, Stryker Corporation, Orthofix International N.V., NuVasive, Inc., Zimmer Biomet Holdings, Inc., Globus Medical, Inc., Alphatec Holdings, Inc., K2M Group Holdings, Inc., and LDR Holding Corporation Browse More@ https://www.futuremarketinsights.com/reports/spinal-stenosis-market Spinal Stenosis Market: Segmentation The global spinal stenosis market is segmented based on product type, treatment type end user and region. Based on Product Type:
Based on treatment type:
Based on end user type:
Like it? Share it!More by this author |